Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 2176 - 2200 of 6046 in total
Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
1-alkyl,2-acylglycerophosphoethanolamine glycans LMGP21020004
  • Am-PE(O-18:0/18:2(9Z,12Z))
  • N-(1-deoxyfructosyl)-1-octadecyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine
 171119248 891.620067 C47H90NO12P
1-alkyl,2-acylglycerophosphoethanolamine glycans LMGP21020006
  • Am-PE(O-18:0/20:4(5Z,8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-octadecyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
 171119249 915.620067 C49H90NO12P
1-alkyl,2-acylglycerophosphoethanolamine glycans LMGP21020007
  • Am-PE(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • N-(1-deoxyfructosyl)-1-(octadecyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
 171119250 939.620067 C51H90NO12P
1-alkyl,2-acylglycerophosphoethanolamine glycans LMGP21020002
  • Am-PE(O-20:0/20:4(5Z,8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-eicosanyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
 171119251 943.651367 C51H94NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030009
  • Am-PE(P-16:0/18:1(9Z))
  • N-(1-deoxyfructosyl)-1-(1Z-hexadecenyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine
 171119252 865.604417 C45H88NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030011
  • Am-PE(P-16:0/20:4(5Z,8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-(1Z-hexadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine
 171119253 885.573117 C47H84NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030001
  • Am-PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • N-(1-deoxyfructosyl)-1-O-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
 171119254 909.573117 C49H84NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030004
  • Am-PE(P-18:0/18:1(9Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine
 171119255 893.635717 C47H92NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030010
  • Am-PE(P-18:0/18:2(9Z,12Z))
  • N-(1-deoxyfructosyl)-1-(1Z-hexadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine
 171119257 861.573117 C45H84NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030008
  • Am-PE(P-18:0/18:2(9Z,12Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine
 171119256 889.604417 C47H88NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030006
  • Am-PE(P-18:0/20:3(8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphoethanolamine
 171119258 915.620067 C49H90NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030007
  • Am-PE(P-18:0/20:4(5Z,8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
 171119259 913.604417 C49H88NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030005
  • Am-PE(P-18:0/22:4(7Z,10Z,13Z,16Z))
  • N-(1-deoxyfructosyl)-1-(1Z-octadecenyl)-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphoethanolamine
 171119260 941.635717 C51H92NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030002
  • Am-PE(P-20:0/18:2(9Z,12Z))
  • N-(1-deoxyfructosyl)-1-(1Z-eicosenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine
 171119261 917.635717 C49H92NO12P
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans LMGP21030003
  • Am-PE(P-20:0/20:4(5Z,8Z,11Z,14Z))
  • N-(1-deoxyfructosyl)-1-(1Z-eicosenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphoethanolamine
 171119262 941.635717 C51H92NO12P
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA00
  • Amino CTH, Lc3Cer
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
 GSG1201 17103
Ascarosides LMFA13040156
  • Asc C11 EA
  • N-(10R-(3,6-dideoxy-alpha-L-arabinosyloxy)-3R,8R-dihydroxy-undecanoyl) ethanolamine
 171116407 375.262089 C19H37NO6
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP00
  • B-IV antigen
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP01
  • B-IV antigen(d18:1/16:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261844 2938.36801 C126H219N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP02
  • B-IV antigen(d18:1/18:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261845 2966.39931 C128H223N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP03
  • B-IV antigen(d18:1/20:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261846 2994.43061 C130H227N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP04
  • B-IV antigen(d18:1/22:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44261847 3022.46191 C132H231N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP05
  • B-IV antigen(d18:1/24:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261848 3050.49321 C134H235N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP07
  • B-IV antigen(d18:1/24:1(15Z))
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44261850 3048.47756 C134H233N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP06
  • B-IV antigen(d18:1/26:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261849 3078.52451 C136H239N5O71
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024